{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:19:55Z","timestamp":1791415195234,"version":"4.3.3"},"reference-count":146,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FEMS Microbiol Rev"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1111\/j.1574-6976.2003.tb00628.x","type":"journal-article","created":{"date-parts":[[2006,1,9]],"date-time":"2006-01-09T11:17:16Z","timestamp":1136805436000},"page":"511-532","source":"Crossref","is-referenced-by-count":239,"title":["Mechanism of action of oritavancin and related glycopeptide antibiotics"],"prefix":"10.1093","volume":"26","author":[{"given":"Norris E.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia I.","family":"Nicas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,1,1]]},"reference":[{"key":"2015070913164062000_26.5.511.1","unstructured":"McCormick, M.H., Stark, W.M., Pittenger, G.E., Pittenger, R.C. and McGuire, J.M. (1956) Vancomycin, a new antibiotic. I. Chemical and biological properties. Antibiot. Annu. 1955\u20131956, 606\u2013611."},{"key":"2015070913164062000_26.5.511.2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.12.2291"},{"key":"2015070913164062000_26.5.511.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807213190307"},{"key":"2015070913164062000_26.5.511.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)18851-3"},{"key":"2015070913164062000_26.5.511.5","unstructured":"Nicas, T.I. and Allen, N.E. (1994) In: Glycopeptide Antibiotics (Nagarajan, R., Ed.), pp. 219\u2013241. Marcel Dekker, New York."},{"key":"2015070913164062000_26.5.511.6","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967563"},{"key":"2015070913164062000_26.5.511.7","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(96)10063-9"},{"key":"2015070913164062000_26.5.511.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-5521(96)90079-4"},{"key":"2015070913164062000_26.5.511.9","doi-asserted-by":"publisher","DOI":"10.1021\/ar00022a006"},{"key":"2015070913164062000_26.5.511.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.8.1563"},{"key":"2015070913164062000_26.5.511.11","unstructured":"Yao, R.C. and Crandall, L.W. (1994) In: Glycopeptide Antibiotics (Nagarajan, R., Ed.). pp. 1\u201327. Marcel Dekker, New York."},{"key":"2015070913164062000_26.5.511.12","doi-asserted-by":"crossref","unstructured":"Kleinkauf H. Von Dohren H. (1996) A nonribosomal system of peptide biosynthesis. Eur. J. Biochem. 236, 335\u2013351.","DOI":"10.1111\/j.1432-1033.1996.00335.x"},{"key":"2015070913164062000_26.5.511.13","doi-asserted-by":"crossref","unstructured":"Nicolaou K.C. Boddy C.N.C. Brase S. Winssinger N. (1999) Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew. Chem. Int. Ed. 38, 2097\u20132152.","DOI":"10.1002\/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F"},{"key":"2015070913164062000_26.5.511.14","unstructured":"Nagarajan, R. (1994) In: Glycopeptide Antibiotics (Nagarajan, R., Ed.), pp. 195\u2013218. Marcel Dekker, New York."},{"key":"2015070913164062000_26.5.511.15","doi-asserted-by":"crossref","unstructured":"Nicas T.I. Mullen D.L. Flokowitsch J.E. Preston D.A. Snyder N.J. Stratford R.E. Cooper R.D.D. (1995) Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob. Agents Chemother. 39, 285\u2013287.","DOI":"10.1128\/AAC.39.11.2585"},{"key":"2015070913164062000_26.5.511.16","doi-asserted-by":"crossref","unstructured":"Rodriguez M.J. et al. (1998) Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci. J. Antibiot. 51, 560\u2013569.","DOI":"10.7164\/antibiotics.51.560"},{"key":"2015070913164062000_26.5.511.17","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.46.1181"},{"key":"2015070913164062000_26.5.511.18","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.49.575"},{"key":"2015070913164062000_26.5.511.19","doi-asserted-by":"crossref","unstructured":"Nicas T.I. et al. (1996) Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 40, 2194\u20132199.","DOI":"10.1128\/AAC.40.9.2194"},{"key":"2015070913164062000_26.5.511.20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.5.705"},{"key":"2015070913164062000_26.5.511.21","doi-asserted-by":"crossref","unstructured":"Baltch A.L. Smith R.P. Ritz W.J. Bopp L.H. (1998) Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium . Antimicrob. Agents Chemother. 42, 2564\u20132568.","DOI":"10.1128\/AAC.42.10.2564"},{"key":"2015070913164062000_26.5.511.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1974.tb43276.x"},{"key":"2015070913164062000_26.5.511.23","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3002(61)90698-9"},{"key":"2015070913164062000_26.5.511.24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.6.6.722"},{"key":"2015070913164062000_26.5.511.25","doi-asserted-by":"crossref","unstructured":"Anderson J.S. Matsuhashi M. Haskin M.A. Strominger J.L. (1967) Biosynthesis of the peptidoglycan of bacterial cell walls. II. Phospholipid carriers in the reaction sequence. J. Biol. Chem. 242, 3180\u20133190.","DOI":"10.1016\/S0021-9258(18)95949-1"},{"key":"2015070913164062000_26.5.511.26","doi-asserted-by":"crossref","unstructured":"Jordan D.C. (1961) Effect of vancomycin on the synthesis of the cell wall mucopeptide of Staphylococcus aureus . Biochem. Biophys. Res. Commun. 6, 167\u2013170.","DOI":"10.1016\/0006-291X(61)90122-X"},{"key":"2015070913164062000_26.5.511.27","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90765-4"},{"key":"2015070913164062000_26.5.511.28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.38.100184.002011"},{"key":"2015070913164062000_26.5.511.29","doi-asserted-by":"crossref","unstructured":"Cristofaro M.F. Beauregard D.A. Yan H. Osborn N.J. Williams D.H. (1995) Cooperativity between non-polar and ionic forces in the binding of bacterial cell wall analogues by vancomycin in aqueous solution. J. Antibiot. 48, 805\u2013810.","DOI":"10.7164\/antibiotics.48.805"},{"key":"2015070913164062000_26.5.511.30","doi-asserted-by":"publisher","DOI":"10.1042\/bj1260139"},{"key":"2015070913164062000_26.5.511.31","doi-asserted-by":"crossref","unstructured":"Allen N.E. LeTourneau D.L. Hobbs J.N. Jr. (1997) Molecular interactions of a semisynthetic glycopeptide antibiotic with d-alanyl-d-alanine and d-alanyl-d-lactate residues. Antimicrob. Agents Chemother. 41, 66\u201371.","DOI":"10.1128\/AAC.41.1.66"},{"key":"2015070913164062000_26.5.511.32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.781"},{"key":"2015070913164062000_26.5.511.33","unstructured":"Williams D.H. Westwell M.S. (1996) The fight against antibiotic-resistant bacteria. Chemtech 26, 17\u201323."},{"key":"2015070913164062000_26.5.511.34","doi-asserted-by":"crossref","unstructured":"Beauregard D.A. Maguire A.J. Williams D.H. Reynolds P.E. (1997) Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms. Antimicrob. Agents Chemother. 41, 2418\u20132423.","DOI":"10.1128\/AAC.41.11.2418"},{"key":"2015070913164062000_26.5.511.35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.3.504"},{"key":"2015070913164062000_26.5.511.36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.3.497"},{"key":"2015070913164062000_26.5.511.37","doi-asserted-by":"publisher","DOI":"10.1021\/ja00090a006"},{"key":"2015070913164062000_26.5.511.38","doi-asserted-by":"crossref","unstructured":"Mackay J.P. Gerhard U. Beauregard D.A. Maplestone R.A. Williams D.H. (1994) Dissection of the contributions towards dimerization of glycopeptide antibiotics. J. Am. Chem. Soc. 116, 4573\u20134580.","DOI":"10.1021\/ja00090a005"},{"key":"2015070913164062000_26.5.511.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(94)00075-1"},{"key":"2015070913164062000_26.5.511.40","doi-asserted-by":"crossref","unstructured":"Gerhard U. Mackay J.P. Maplestone R.A. Williams D.H. (1993) The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics. J. Am. Chem. Soc. 115, 232\u2013237.","DOI":"10.1021\/ja00054a033"},{"key":"2015070913164062000_26.5.511.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-5521(96)90264-1"},{"key":"2015070913164062000_26.5.511.42","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C"},{"key":"2015070913164062000_26.5.511.43","doi-asserted-by":"crossref","unstructured":"Arthur M. Molinas C. Courvalin P. (1992) The vanS-vanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 174, 2582\u20132591.","DOI":"10.1128\/jb.174.8.2582-2591.1992"},{"key":"2015070913164062000_26.5.511.44","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90405-Z"},{"key":"2015070913164062000_26.5.511.45","doi-asserted-by":"publisher","DOI":"10.1021\/bi00107a007"},{"key":"2015070913164062000_26.5.511.46","doi-asserted-by":"publisher","DOI":"10.1021\/bi00222a002"},{"key":"2015070913164062000_26.5.511.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1994.tb00497.x"},{"key":"2015070913164062000_26.5.511.48","doi-asserted-by":"publisher","DOI":"10.1021\/bi00008a008"},{"key":"2015070913164062000_26.5.511.49","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.1899"},{"key":"2015070913164062000_26.5.511.50","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.7.1514"},{"key":"2015070913164062000_26.5.511.51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.1.77"},{"key":"2015070913164062000_26.5.511.52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1996.00617.x"},{"key":"2015070913164062000_26.5.511.53","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050159"},{"key":"2015070913164062000_26.5.511.54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.1.84"},{"key":"2015070913164062000_26.5.511.55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1992.tb05498.x"},{"key":"2015070913164062000_26.5.511.56","doi-asserted-by":"publisher","DOI":"10.1042\/bj3010005"},{"key":"2015070913164062000_26.5.511.57","doi-asserted-by":"crossref","unstructured":"Billot-Klein D. Blanot D. Gutmann L. van Heijenoort J. (1994) Association constants for the binding of vancomycin and teicoplainin to N-acetyl-d-alanyl-d-alanine and N-acetyl-d-alanyl-d-serine. Biochem. J. Lett. 304, 1021\u20131022.","DOI":"10.1042\/bj3041021"},{"key":"2015070913164062000_26.5.511.58","doi-asserted-by":"crossref","unstructured":"Billot-Klein D. Gutmann L. Sable S. Guittet E. van Heijenoort J. (1994) Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant vanB-type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum . J. Bacteriol. 176, 2398\u20132405.","DOI":"10.1128\/jb.176.8.2398-2405.1994"},{"key":"2015070913164062000_26.5.511.59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.19.10040"},{"key":"2015070913164062000_26.5.511.60","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.8.1788"},{"key":"2015070913164062000_26.5.511.61","doi-asserted-by":"crossref","unstructured":"Handwerger S. Pucci M.J. Volk K.J. Liu J. Lee M.S. (1994) Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic precursors that terminate in lactate. J. Bacteriol. 176, 260\u2013264.","DOI":"10.1128\/jb.176.1.260-264.1994"},{"key":"2015070913164062000_26.5.511.62","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(98)80029-0"},{"key":"2015070913164062000_26.5.511.63","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2276-2285.2000"},{"key":"2015070913164062000_26.5.511.64","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.2.199"},{"key":"2015070913164062000_26.5.511.65","doi-asserted-by":"crossref","unstructured":"Sieradzki K. Tomasz A. (1997) Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus . J. Bacteriol. 179, 2557\u20132566.","DOI":"10.1128\/jb.179.8.2557-2566.1997"},{"key":"2015070913164062000_26.5.511.66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.27.18942"},{"key":"2015070913164062000_26.5.511.67","doi-asserted-by":"crossref","unstructured":"Noble W.C. Virani Z. Cree R.G. (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus . FEMS Microbiol. Lett. 72, 195\u2013198.","DOI":"10.1111\/j.1574-6968.1992.tb05089.x"},{"key":"2015070913164062000_26.5.511.68","unstructured":"Sievert D.M. et al. (2002) Staphylococcus aureus resistant to vancomycin. Morb. Mort. Weekly Rep. 51, 565\u2013567."},{"key":"2015070913164062000_26.5.511.69","unstructured":"Barrett J.F. (2001) Oritavancin Eli Lilly&Co. Curr. Opin. Invest. Drugs 2, 1039\u20131044."},{"key":"2015070913164062000_26.5.511.70","unstructured":"Johnson A.P. (1999) LY-333328 Eli Lilly. Curr. Opin. Anti-Infect. Invest. Drugs 1, 87\u201395."},{"key":"2015070913164062000_26.5.511.71","unstructured":"Muller-Serieys, C., Vallee, E., Pangon, B., Chachaty, E. and Decre, E. (1997) In vitro activity of oritavancin, a new glycopeptide, against gram-positive cocci. In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, ON, September 28\u2013October 1, F-3, p. 146."},{"key":"2015070913164062000_26.5.511.72","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.2.273"},{"key":"2015070913164062000_26.5.511.73","doi-asserted-by":"crossref","unstructured":"Biavasco F. Vignaroli C. Lupidi R. Manso E. Facinelli B. Varaldo P.E. (1997) In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide. Antimicrob. Agents Chemother. 41, 2165\u20132172.","DOI":"10.1128\/AAC.41.10.2165"},{"key":"2015070913164062000_26.5.511.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(97)00207-1"},{"key":"2015070913164062000_26.5.511.75","doi-asserted-by":"crossref","unstructured":"Canton R. Mir N. Sanchez M. Baquero F. (1999) MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care unit patient surveillance cultures. Clin. Microbiol. Infect. 5, 554\u2013559.","DOI":"10.1111\/j.1469-0691.1999.tb00434.x"},{"key":"2015070913164062000_26.5.511.76","doi-asserted-by":"crossref","unstructured":"Garcia-Garrote F. Cercenado E. Alcala L. Bouza E. (1998) In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob. Agents Chemother. 42, 2452\u20132455.","DOI":"10.1128\/AAC.42.9.2452"},{"key":"2015070913164062000_26.5.511.77","doi-asserted-by":"crossref","unstructured":"Jones R.N. Barrett M.S. Erwin M.E. (1997) In vitro activity and spectrum of LY333328, a novel glycopeptide derivative. Antimicrob. Agents Chemother. 41, 488\u2013493.","DOI":"10.1128\/AAC.41.2.488"},{"key":"2015070913164062000_26.5.511.78","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.5.1370-1374.2000"},{"key":"2015070913164062000_26.5.511.79","doi-asserted-by":"crossref","unstructured":"Fasola E. Spangler S.K. Ednie L.M. Jacobs M.R. Bajaksouzian S. Appelbaum P.C. (1996) Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40, 2661\u20132663.","DOI":"10.1128\/AAC.40.11.2661"},{"key":"2015070913164062000_26.5.511.80","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.4.563"},{"key":"2015070913164062000_26.5.511.81","unstructured":"Reynolds, P. (1997) High-level glycopeptide-resistant Staphylococcus aureus is susceptible to glycopeptide, oritavancin. In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, ON, September 28\u2013October 1, C-165, p. 74."},{"key":"2015070913164062000_26.5.511.82","doi-asserted-by":"crossref","unstructured":"Sillerstrom E. Wahlund E. Nord C.E. (1999) In vitro activity of LY 333328 against anaerobic Gram-positive bacteria. J. Chemother. (Firenze) 11, 90\u201392.","DOI":"10.1179\/joc.1999.11.2.90"},{"key":"2015070913164062000_26.5.511.83","unstructured":"Heine, H.S., Dicks, R. and Andres, G. (2001) In vitro activity of LY333328 (oritavancin), levofloxacin, meropenem, GAR936, and linezolid against strains of Bacillus anthracis. In: Abstracts, 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 22\u201325, E-524, p. 173."},{"key":"2015070913164062000_26.5.511.84","unstructured":"Nicas, T.I., Mullen, D.L., Flokowitsch, J.E. and Preston, D.A. (1996) Bactericidal activity against enterococci of the semisynthetic glycopeptide oritavancin. In: Abstracts, 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, September 15\u201318, F198, p. 134."},{"key":"2015070913164062000_26.5.511.85","unstructured":"Boylan, C.J. et al. (1995) Efficacy of semisynthetic glycopeptides active against vancomycin-resistant enterococci in a mouse infection model. In: Abstracts, 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, September 17\u201320, F255, p. 157."},{"key":"2015070913164062000_26.5.511.86","doi-asserted-by":"crossref","unstructured":"Mercier R.-C. Penzak S.R. Rybak M.J. (1997) In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium . Antimicrob. Agents Chemother. 41, 2573\u20132575.","DOI":"10.1128\/AAC.41.11.2573"},{"key":"2015070913164062000_26.5.511.87","doi-asserted-by":"crossref","unstructured":"Mercier R.-C. Houlihan H.H. Rybak M.J. (1997) Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium . Antimicrob. Agents Chemother. 41, 1307\u20131312.","DOI":"10.1128\/AAC.41.6.1307"},{"key":"2015070913164062000_26.5.511.88","doi-asserted-by":"crossref","unstructured":"Zelenitsky S.A. Karlowsky J.A. Zhanel G.G. Hoban D.J. Nicas T. (1997) Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-sensitive and vancomycin-resistant Enterococcus faecium strains. J. Antimicrob. Chemother. 41, 1407\u20131408.","DOI":"10.1128\/AAC.41.6.1407"},{"key":"2015070913164062000_26.5.511.89","doi-asserted-by":"crossref","unstructured":"Schwalbe R.S. McIntosh A.C. Qaiyumi S. Johnson J.A. Johnson R.J. Furness K.M. Holloway W.J. Steele-Moore L. (1996) In vitro activity of LY3333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob. Agents Chemother. 40, 2416\u20132419.","DOI":"10.1128\/AAC.40.10.2416"},{"key":"2015070913164062000_26.5.511.90","unstructured":"Donabedian, S., Perri, M.B., Thal, L.A. and Zervos, M.J. (1996) Comparative in-vitro and bactericidal activity of oritavancin against multi-drug resistant enterococci. In: Abstracts, 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, September 15\u201318, F204, p. 135."},{"key":"2015070913164062000_26.5.511.91","unstructured":"Cheron, M. and Boisivon, A. (1997) In vitro bactericidal effect of LY 333328 against vancomycin resistant and susceptible Enterococcus faecium. In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, ON, September 28\u2013October 1, F-8, p. 147."},{"key":"2015070913164062000_26.5.511.92","unstructured":"Nicas, T.I. et al. (1995) Semisynthetic glycopeptides active against vancomycin-resistant enterococci: activity against staphylococci and streptococci in vitro and in vivo. In: Abstracts, 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, September 17\u201320, F248, p. 156."},{"key":"2015070913164062000_26.5.511.93","unstructured":"Sloos, J.H., Van de Klundert, J.A.M., Seymonson, G. and Vanboven, C.P. (1997) Susceptibility of coagulase-negative staphylococci to a new glycopeptide (oritavancin). In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, ON, September 28\u2013October 1, F-6, p. 147."},{"key":"2015070913164062000_26.5.511.94","doi-asserted-by":"crossref","unstructured":"Hershberger E. Aeschlimann J.R. Moldovan T. Rybak M.J. (1999) Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods. Antimicrob. Agents Chemother. 43, 717\u2013721.","DOI":"10.1128\/AAC.43.3.717"},{"key":"2015070913164062000_26.5.511.95","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.706-709.2001"},{"key":"2015070913164062000_26.5.511.96","unstructured":"Cha R. Rybak M.J. (2001) Characterization of the activities of linezolid, oritavancin, levofloxacin and vancomycin against vancomycin-tolerant Streptococcus pneumoniae . Pharmacotherapy 21, 347\u2013352."},{"key":"2015070913164062000_26.5.511.97","doi-asserted-by":"crossref","unstructured":"Loll P.J. Kaplan J. Selinsky B.S. Axelsen P.H. (1999) Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding. J. Med. Chem. 42, 4714\u20134719.","DOI":"10.1021\/jm990361t"},{"key":"2015070913164062000_26.5.511.98","doi-asserted-by":"crossref","unstructured":"Arthur M. Depardieu F. Reynolds P. Courvalin P. (1999) Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci. Antimicrob. Agents Chemother. 43, 1875\u20131880.","DOI":"10.1128\/AAC.43.8.1875"},{"key":"2015070913164062000_26.5.511.99","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.3.406"},{"key":"2015070913164062000_26.5.511.100","doi-asserted-by":"crossref","unstructured":"Allen N.E. Hobbs J.N. Jr. Nicas T.I. (1996) Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic. Antimicrob. Agents Chemother. 40, 2356\u20132362.","DOI":"10.1128\/AAC.40.10.2356"},{"key":"2015070913164062000_26.5.511.101","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.7.1093"},{"key":"2015070913164062000_26.5.511.102","doi-asserted-by":"crossref","unstructured":"Hammes W.P. Neuhaus F.C. (1974) Biosynthesis of peptidoglycan in Gaffkya homari: role of the peptide subunit of uridine diphosphate-N-acetyl-muramyl-pentapeptide. J. Bacteriol. 120, 210\u2013218.","DOI":"10.1128\/JB.120.1.210-218.1974"},{"key":"2015070913164062000_26.5.511.103","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5413.507"},{"key":"2015070913164062000_26.5.511.104","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-5521(01)00075-8"},{"key":"2015070913164062000_26.5.511.105","doi-asserted-by":"crossref","unstructured":"Allen N.E. LeTourneau D.L. Hobbs J.N. Jr. (1997) The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics. J. Antibiot. 50, 677\u2013684.","DOI":"10.7164\/antibiotics.50.677"},{"key":"2015070913164062000_26.5.511.106","unstructured":"Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H. and Waring, M.J. (1981) The molecular basis of antibiotic action. Wiley, New York."},{"key":"2015070913164062000_26.5.511.107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2000.tb08959.x"},{"key":"2015070913164062000_26.5.511.108","doi-asserted-by":"publisher","DOI":"10.1021\/ja0027665"},{"key":"2015070913164062000_26.5.511.109","doi-asserted-by":"crossref","unstructured":"Pavlov A.Y. et al. (2001) Synthesis of hydrophobic N\u2032-mono and N\u2032,N\u2033-double alkylated eremomycins inhibiting the transglycosylation stage of bacterial cell wall biosynthesis. J. Antibiot. 54, 455\u2013459.","DOI":"10.7164\/antibiotics.54.455"},{"key":"2015070913164062000_26.5.511.110","doi-asserted-by":"publisher","DOI":"10.1021\/jm010460i"},{"key":"2015070913164062000_26.5.511.111","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(82)90053-5"},{"key":"2015070913164062000_26.5.511.112","doi-asserted-by":"crossref","unstructured":"Chu Y.-H. Avila L.Z. Gao J. Whitesides G.M. (1995) Affinity capillary electrophoresis. Acc. Chem. Res. 28, 461\u2013468.","DOI":"10.1021\/ar00059a004"},{"key":"2015070913164062000_26.5.511.113","doi-asserted-by":"crossref","unstructured":"Good V.M. Gwynn M.N. Knowles D.J.C. (1990) MM45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-l-lysyl-d-alanyl-d-alanine. J. Antibiot. 43, 550\u2013555.","DOI":"10.7164\/antibiotics.43.550"},{"key":"2015070913164062000_26.5.511.114","doi-asserted-by":"crossref","unstructured":"Sharman G.J. and Williams, D.H. (1997) Common factors in the mode of action of vancomycin group antibiotics active against resistant bacteria. Chem. Commun. (Cambridge) 1997, 723\u2013724.","DOI":"10.1039\/a608477j"},{"key":"2015070913164062000_26.5.511.115","doi-asserted-by":"publisher","DOI":"10.1042\/bj1230773"},{"key":"2015070913164062000_26.5.511.116","doi-asserted-by":"crossref","unstructured":"Prowse W.G. Kline A.D. Skelton M.A. Loncharich R.J. (1995) Conformation of A82846B, a glycopeptide antibiotic, complexed with its cell wall fragment: an asymmetric homodimer determined using NMR spectroscopy. Biochemistry 34, 9632\u20139644.","DOI":"10.1021\/bi00029a041"},{"key":"2015070913164062000_26.5.511.117","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1997.2004"},{"key":"2015070913164062000_26.5.511.118","doi-asserted-by":"publisher","DOI":"10.1021\/ja971225l"},{"key":"2015070913164062000_26.5.511.119","doi-asserted-by":"publisher","DOI":"10.1021\/ja9621298"},{"key":"2015070913164062000_26.5.511.120","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(98)00895-8"},{"key":"2015070913164062000_26.5.511.121","doi-asserted-by":"publisher","DOI":"10.1002\/1521-3765(20010903)7:17&lt;3824::AID-CHEM3824&gt;3.0.CO;2-1"},{"key":"2015070913164062000_26.5.511.122","unstructured":"Stack, D.R., LeTourneau, D.L., Mullen, D.L., Butler, T.F., Allen, N.E., Kline, A.D., Nicas, T.I. and Thompson, R.C. (1997) Covalent glycopeptide dimers: synthesis, physical characterization, and antibacterial activity. In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, ON, September 28\u2013October 1, F-1."},{"key":"2015070913164062000_26.5.511.123","doi-asserted-by":"crossref","unstructured":"Cooper M.A. Williams D.H. Cho Y.R. (1997) Surface plasmon resonance analysis of glycopeptide antibiotic activity at a model membrane surface. J. Chem. Soc. Chem. Commun. 1997, 1625\u20131626.","DOI":"10.1039\/a703943c"},{"key":"2015070913164062000_26.5.511.124","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-5521(00)80008-3"},{"key":"2015070913164062000_26.5.511.125","doi-asserted-by":"publisher","DOI":"10.1021\/ja964477f"},{"key":"2015070913164062000_26.5.511.126","doi-asserted-by":"crossref","unstructured":"Westwell M.S. Bardsley B. Dancer R.J. Try C. Williams D.H. (1996) Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics. J. Chem. Soc. Chem. Commun. 1996, 589\u2013590.","DOI":"10.1039\/cc9960000589"},{"key":"2015070913164062000_26.5.511.127","doi-asserted-by":"crossref","unstructured":"Searle M.S. et al. (1996) Enthalpic (electrostatic) contribution to the chelate effect: a correlation between ligand binding constant and a specific hydrogen bond strength in complexes of glycopeptide antibiotics with cell wall analogs. J. Chem. Soc. Perkin Trans. 1, 2781\u20132786.","DOI":"10.1039\/p19960002781"},{"key":"2015070913164062000_26.5.511.128","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5364.711"},{"key":"2015070913164062000_26.5.511.129","doi-asserted-by":"crossref","unstructured":"Linsdell H. Toiron C. Bruix M. Rivas G. Menendez M. (1996) Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. J. Antibiot. 49, 181\u2013193.","DOI":"10.7164\/antibiotics.49.181"},{"key":"2015070913164062000_26.5.511.130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.7.4046"},{"key":"2015070913164062000_26.5.511.131","doi-asserted-by":"crossref","unstructured":"Try A.C. Sharman G.J. Dancer R.J. Bardsley B. Entress R.M.H. Williams D.H. (1997) Use of model cell membranes to demonstrate templated binding of vancomycin group antibiotics. J. Chem. Soc. Perkin Trans. 1, 2911\u20132917.","DOI":"10.1039\/a701880k"},{"key":"2015070913164062000_26.5.511.132","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-5521(98)90171-5"},{"key":"2015070913164062000_26.5.511.133","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2344-2348.2002"},{"key":"2015070913164062000_26.5.511.134","unstructured":"Wilkie, S.C., LeTourneau, D.L., Mullen, D.L., Butler, T.F., Allen, N.E., Nicas, T.I. and Thompson, R.C. (1998) N-terminal modification of glycopeptide antibiotics: synthesis, antibacterial activity and mechanism of action. In: Abstracts, 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24\u201327, F-115."},{"key":"2015070913164062000_26.5.511.135","doi-asserted-by":"crossref","unstructured":"Williams D.H. (1996) The glycopeptide story - How to kill the deadly \u2018superbugs\u2019. Nat. Prod. Res. 13, 469\u2013477.","DOI":"10.1039\/NP9961300469"},{"key":"2015070913164062000_26.5.511.136","doi-asserted-by":"crossref","unstructured":"Goldman R.C. Gange D. (2000) Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis. Curr. Med. Chem. 7, 801\u2013820.","DOI":"10.2174\/0929867003374651"},{"key":"2015070913164062000_26.5.511.137","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00471-X"},{"key":"2015070913164062000_26.5.511.138","doi-asserted-by":"crossref","unstructured":"Frank U. Jonas D. Lupke T. Ribeiro-Ayeh E. Schmidt-Eisenlohr E. Daschner F.D. Resistance T.N.R.C.S.G.f.A. (2000) Antimicrobial susceptibilities among nosocomial pathogens isolated in intensive care units in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 19, 888\u2013891.","DOI":"10.1007\/s100960000389"},{"key":"2015070913164062000_26.5.511.139","unstructured":"Hoban, D., Cox, L., Palatnick, L., Weshnoweski, B., Kabani, A., Zelenitsky, S., Karlowsky, J. and Zhanel, G. (1997) Comparative in vitro activity of oritavancin, a new glycopeptide, against Enterococcus gallinarum and Enterococcus casseliflavus. In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, ON, September 28\u2013October 1, F-7, p. 24."},{"key":"2015070913164062000_26.5.511.140","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.2.266"},{"key":"2015070913164062000_26.5.511.141","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.2.283"},{"key":"2015070913164062000_26.5.511.142","doi-asserted-by":"crossref","unstructured":"Schouten M.A. Voss A. Hoogkamp-Korstanje J.A. (1999) Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrob. Agents Chemother. 43, 2542\u20132546.","DOI":"10.1128\/AAC.43.10.2542"},{"key":"2015070913164062000_26.5.511.143","doi-asserted-by":"crossref","unstructured":"Sanchez-Silos R.M. Perez-Giraldo C. Blanco M.T. Moran F.J. Hurtado C. Gomez-Garcia A.C. (2001) Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin. Chemotherapy (Basel) 47, 415\u2013420.","DOI":"10.1159\/000048552"},{"key":"2015070913164062000_26.5.511.144","doi-asserted-by":"crossref","unstructured":"Struwig M.C. Botha P.L. Chalkley L.J. (1998) In vitro activities of 15 antimicrobial agents against clinical isolates of South African enterococci. Antimicrob. Agents Chemother. 42, 2752\u20132755.","DOI":"10.1128\/AAC.42.10.2752"},{"key":"2015070913164062000_26.5.511.145","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.2.179"},{"key":"2015070913164062000_26.5.511.146","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.3.423"}],"container-title":["FEMS Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsre\/article-pdf\/26\/5\/511\/18126476\/26-5-511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T10:02:38Z","timestamp":1626948158000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsre\/article-lookup\/doi\/10.1111\/j.1574-6976.2003.tb00628.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":146,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2003,1,1]]},"published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1111\/j.1574-6976.2003.tb00628.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1574-6976.2003.tb00628.x","relation":{},"ISSN":["1574-6976"],"issn-type":[{"value":"1574-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}